Cover Image
市場調查報告書

印度的醫藥品、醫療產業(季度更新報告)

India Pharmaceuticals & Healthcare Q2 2018

出版商 BMI Research 商品編碼 191492
出版日期 內容資訊 英文 99 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印度的醫藥品、醫療產業(季度更新報告) India Pharmaceuticals & Healthcare Q2 2018
出版日期: 2018年01月30日 內容資訊: 英文 99 Pages
簡介

本報告提供印度的製藥、醫療產業結構和最新趨勢相關分析,產業今後10年的產業規模的動向的估計,課題(風險)和未來商機(利潤)相關評估,政府的政策、規定,宏觀經濟環境,主要企業簡介等資訊彙整,為您概述為以下內容。

BMI的見解

SWOT分析

產業預測

  • 醫藥品市場預測
  • 醫療市場預測
  • 處方藥市場預測
  • 專利藥市場預測
  • 學名藥市場預測
  • 一般用(OTC)醫藥品市場預測
  • 醫藥品的對外貿易情形

產業的風險/利潤、等級

  • 亞太地區的製藥產業:多樣的機會與固有的風險
  • 產業的風險/利潤、等級

法規

  • 知識產權問題
  • 價格政策

市場概況

  • 醫療部門
  • 研究開發(R&D)
  • 臨床實驗
  • 流行病學

競爭環境

  • 研究為基礎的產業
  • 醫藥品的流通結構
  • 醫藥品的零售部門

企業簡介

  • Aurobindo Pharmaceutical
  • Cipla
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi India
  • Sun Pharmaceutical

人口結構的預測

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關注記
  • 風險/利潤、等級技術

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: SSIN03_20180401

BMI View: India's pharmaceutical market is forecast to expand at a relatively rapid rate over the coming years, supported by a range of industry-specific and demographic factors including greater urbanisation and a growing prevalence of non-communicable diseases. However, a tough pricing environment, low levels of intellectual property protection, preference for generic medicines and low per capita pharmaceutical and healthcare spending are ongoing concerns for multinational drugmakers.

Table of Contents

  • BMI Industry View
    • Table: Headline Pharmaceuticals & Healthcare Forecasts (India 2016-2022)
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
    • Table: Pharmaceutical Sales, Historical Data And Forecasts (India 2014-2022)
  • Healthcare Market Forecast
    • Table: Healthcare Expenditure Trends, Historical Data And Forecasts (India 2014-2022)
    • Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (India 2014-2022)
    • Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (India 2014-2022)
  • Prescription Drug Market Forecast
    • Table: Prescription Drug Market Indicators, Historical Data And Forecasts (India 2014-2022)
  • Patented Drug Market Forecast
    • Table: Patented Drug Market Indicators, Historical Data And Forecasts (India 2014-2022)
  • Generic Drug Market Forecast
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (India 2014-2022)
  • OTC Medicine Market Forecast
    • Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (India 2014-2022)
  • Pharmaceutical Trade Forecast
    • Table: Pharmaceutical Trade Data And Forecasts (India 2016-2022)
    • Table: Pharmaceutical Trade Data And Forecasts Local Currency (India 2016-2022)
  • Industry Risk/Reward Index
  • Asia Pacific Pharmaceuticals: Diverse Opportunities And Inherent Risks
  • Industry Risk Reward Index
  • Regulatory Review
  • Intellectual Property Issues
    • Table: Special 301 Submission: Issues Raised For India
  • Pricing Regime
  • Market Overview
  • Healthcare Sector
    • Table: Healthcare Resources (India 2012-2017)
    • Table: Healthcare Personnel (India 2012-2017)
    • Table: Healthcare Activity (India 2012-2017)
  • Research & Development
  • Clinical Trials
  • Epidemiology
    • Table: Estimated Number Of New Cases Of Cancer In India

Competitive Landscape

    • Table: Multinational Market Activity
  • Pharmaceutical Distribution
  • Pharmaceutical Retail Sector
  • Company Profile
  • Aurobindo Pharmaceutical
  • Cipla
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi India
  • Sun Pharmaceutical
  • Demographic Forecast
    • Table: Population Headline Indicators (India 1990-2025)
    • Table: Key Population Ratios (India 1990-2025)
    • Table: Urban/Rural Population & Life Expectancy (India 1990-2025)
    • Table: Population By Age Group (India 1990-2025)
    • Table: Population By Age Group % (India 1990-2025)
  • Glossary
  • Methodology
  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top